Bausch Health Americas, Inc.

Quick facts

Marketed products

• Adapalene/Benzoyl Peroxide Facial Gel · Dermatology
  Adapalene is a retinoid that normalizes skin cell turnover and reduces inflammation, while benzoyl peroxide kills acne-causing bacteria and provides additional antimicrobial activity.
• Adapalene Gel · Dermatology
  Adapalene is a third-generation retinoid that binds to retinoic acid receptors to normalize skin cell differentiation and reduce inflammation.
• benzoyl peroxide wash
• Dapsone plus Tretinoin Gel · Dermatology
  Dapsone reduces inflammation and bacterial growth while tretinoin promotes skin cell turnover and normalizes keratinization to treat acne and related inflammatory skin conditions.
• High dose budesonide rectal foam · Gastroenterology / Immunology
  Budesonide is a corticosteroid that suppresses local inflammation in the colon and rectum by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.
• IDP-118 Lotion · Dermatology
  IDP-118 Lotion is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.
• IDP-122 Lotion
• Low dose budesonide rectal foam · Gastroenterology
  Budesonide is a corticosteroid that suppresses local inflammation in the colon and rectum by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.
• Luliconazole Cream 1% · Dermatology
  Luliconazole inhibits fungal lanosterol 14α-demethylase, disrupting ergosterol synthesis in the fungal cell membrane.
• Matching placebo rectal foam
  A placebo rectal foam formulation used as a control comparator in clinical trials.
• Methylnaltrexone (MNTX) · Gastroenterology / Pain Management
  Methylnaltrexone is a peripheral mu-opioid receptor antagonist that blocks opioid receptors in the gastrointestinal tract without crossing the blood-brain barrier, thereby reversing opioid-induced constipation.
• Poly-L-Lactic Acid
• Tazorac Cream
• Tretinoin Facial Gel
• Tretinoin gel · Dermatology
  Tretinoin is a vitamin A derivative that binds to retinoic acid receptors in the nucleus, promoting cell differentiation and reducing sebum production and comedone formation.

Phase 3 pipeline

• ACYC vehicle · Virology/Dermatology
  ACYC vehicle is a topical formulation designed to enhance the delivery and efficacy of acyclovir for localized antiviral treatment.
• Cimetidine IV · Gastroenterology
  Cimetidine is a histamine H2-receptor antagonist that reduces gastric acid secretion by blocking histamine-mediated stimulation of parietal cells.
• double-blind rifaximin · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis.
• Epiduo® Forte Gel · Dermatology
  Epiduo Forte combines adapalene (a retinoid) and benzoyl peroxide to reduce acne by normalizing skin cell turnover and killing acne-causing bacteria.
• Granulated mesalamine · Gastroenterology / Immunology
  Mesalamine is an anti-inflammatory agent that acts locally in the colon to reduce inflammation by inhibiting prostaglandin and leukotriene production.
• IDP-118 Vehicle Lotion · Dermatology
  IDP-118 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.
• IDP-120 Gel · Dermatology
  IDP-120 Gel is a topical retinoid formulation designed to treat acne and other skin conditions by promoting cell turnover and reducing sebum production.
• IDp-120 Vehicle Gel · Dermatology
  IDp-120 is a topical immunomodulatory gel formulation designed to enhance local immune response at the application site.
• IDP 121 Lotion · Dermatology
  IDP 121 is a topical lotion formulation designed to treat inflammatory skin conditions by reducing inflammation and modulating immune response in the skin.
• IDP-121 Vehicle Lotion · Dermatology
  IDP-121 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.
• IDP-122 Vehicle Lotion · Dermatology
  IDP-122 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.
• IDP-123 Lotion · Dermatology
  IDP-123 is a topical lotion formulation designed to treat inflammatory skin conditions by modulating local immune and inflammatory pathways.
• IDP-123 Vehicle Lotion · Dermatology
  IDP-123 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients through the skin for localized or systemic therapeutic effect.
• IDP-124 Lotion · Dermatology
  IDP-124 is a topical lotion formulation combining calcipotriene and betamethasone dipropionate to reduce inflammation and normalize skin cell differentiation in psoriasis.
• IDP-124 Vehicle Lotion · Dermatology
  IDP-124 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients to the skin for localized therapeutic effect.
• IDP-126 Gel · Dermatology
  IDP-126 is a topical retinoid that modulates retinoid receptor signaling to reduce inflammation and promote skin cell differentiation in dermatological conditions.
• IDP-126 Vehicle Gel · Dermatology
  IDP-126 is a topical gel formulation designed to deliver active pharmaceutical ingredients to treat dermatological conditions.
• Methylnaltrexone (MOA-728) · Gastroenterology / Supportive Care
  Methylnaltrexone is a peripheral mu-opioid receptor antagonist that blocks opioid receptors in the gastrointestinal tract without crossing the blood-brain barrier, thereby reversing opioid-induced constipation while preserving central analgesia.
• Neuromultivit · Neuroscience
• open-label rifaximin · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis, thereby reducing bacterial load in the gut.
• Rifaximin SSD · Gastroenterology
  Rifaximin SSD is a non-absorbed antibiotic that inhibits bacterial RNA polymerase to reduce pathogenic gut bacteria.
• SC Methylnaltrexone · Gastrointestinal
  SC Methylnaltrexone is a peripherally acting mu-opioid receptor antagonist that blocks the action of opioids in the gastrointestinal tract.
• SC Methylnaltrexone (MNTX) · Gastroenterology / Supportive Care
  Methylnaltrexone is a peripheral mu-opioid receptor antagonist that blocks opioid receptors in the gastrointestinal tract without crossing the blood-brain barrier, thereby reversing opioid-induced constipation.
• Sirdalud · Other
• tramadol HCl ER; celecoxib · Pain Management
  This combination product uses tramadol (an opioid agonist and monoamine reuptake inhibitor) for pain relief and celecoxib (a selective COX-2 inhibitor) for anti-inflammatory effects.

Phase 2 pipeline

• Fipamezole ODT
• IDP-118 Monad HP Lotion
• IDP-118 Monad Taz Lotion
• IDP 120 Component A Gel
• IDP 120 Component B Gel
• IDP-126 Component A
• IDP-126 Component B
• IDP-126 Component C
• IV Methylnaltrexone
• Low Dose Rifaximin DER · Infectious Disease
  Inhibits bacterial RNA synthesis
• MT-1303
• Retin-A Micro 0.04% facial acne treatment
• SC MNTX
• Ultravate Cream

Phase 1 pipeline

• HP Monad Lotion
• Rifaximin Novel Formulation
• SP-333

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Bausch Health Americas, Inc. portfolio CI brief
• Bausch Health Americas, Inc. pipeline updates RSS

Frequently asked questions about Bausch Health Americas, Inc.

Related

• Adapalene/Benzoyl Peroxide Facial Gel · Dermatology
• Adapalene Gel · Dermatology
• benzoyl peroxide wash
• Dapsone plus Tretinoin Gel · Dermatology
• High dose budesonide rectal foam · Gastroenterology / Immunology
• Sector hub: All tracked pharma companies